ATRA vs CUBE
Atara Biotherapeutics Inc (ATRA) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
ATRA currently screens at market cap $87.1M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the ATRA and CUBE stock pages for the full models.
Not investment advice.